The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of Korea

다국어 초록 (Multilingual Abstract)

Objectives: Measurement of the incidence of the human immunodeficiency virus (HIV) is very important for epidemiological studies. Here, we determined the recency period with the AxSYM avidity assay and the BED-capture enzyme immunoassay (BED-CEIA) in Korean seroconverters.
Methods: Two hundred longitudinal specimens from 81 seroconverters with incident HIV infections that had been collected at the Korea National Institute of Health were subjected to the AxSYM avidity assay (cutoff = 0.8) and BED-CEIA (cutoff = 0.8). The statistical method used to estimate the recency period in recent HIV infections was nonparametric survival analyses. Sensitivity and specificity were calculated for 10-day increments from 120 days to 230 days to determine the recency period.
Results: The mean recency period of the avidity assay and BED-CEIA using a survival method was 158 days [95% confidence interval (CI), 135-181 days] and 189 days (95% CI, 170-208 days), respectively. Based on the use of sensitivity and specificity, the mean recency period for the avidity assay and BED-CEIA was 150 days and 200 days, respectively.
Conclusion: We determined the recency period to estimate HIV incidence in Korea. These data showed that the nonparametric survival analysis often led to shorter recency periods than analysis of sensitivity and specificity as a newmethod.
These findings suggest that more data from seroconverters and other methodologies are needed to determine the recency period for estimating HIV incidence.

참고문헌 (Reference)

1 Kalbfleisch JD, "The statistical analysis of failure time data" John Wiley & Sons, Inc. 1980

2 Parekh BS, "Quantitative detection of increasing HIV type I antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence" 18 (18): 295-307, 2002

3 Suligoi B, "Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method" 40 (40): 4015-4020, 2002

4 Keele BF, "Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection" 105 (105): 7552-7557, 2008

5 Korea Centers for Diseases Control and Prevention, "HIV/AIDS Guideline" Korea Centers for Disease Control and Prevention 2012

6 Levy JA, "HIV and the Pathogenesis of AIDS" ASM Press 2007

7 Prejean J, "HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009" 6 (6): e17502-, 2011

8 Parekh BS, "Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion, among individuals with HIV-1 subtype B or E infection in Thailand" 17 (17): 453-458, 2001

9 Wang JS, "Establishment of modified serological testing for the diagnose of recent HIV infections to estimate HIV incidence in Korea" The Korean Society for AIDS 2012

10 Parekh BS, "Determination of mean recency period for estimation of HIV type 1 incidence with the bed-capture EIA in persons infected with diverse subtypes" 27 (27): 265-273, 2011

11 "Calypte HIV-1 BED incidence EIA (IgG-Capture HIV-EIA):enzyme immunoassay for population estimates of HIV-1 incidence" Calypte Biomedical Corporation 2005

12 Kim NY, "Approach for avidity index assay to detect recent HIV infection in Korea" (D1) : 2013